Literature DB >> 12642008

The effect of aldosterone on glucose metabolism.

Dalila B Corry1, Michael L Tuck.   

Abstract

There is an association of glucose intolerance and diabetes with primary aldosteronism, but the frequency and mechanisms are not clear. This paper reviews the possible mechanisms of impaired glucose metabolism in primary aldosteronism. Patients with primary aldosteronism can have impaired pancreatic insulin release and reduction in insulin sensitivity. These effects may be due to hypokalemia, but the evidence suggests other factors such as a direct impact of excess aldosterone on insulin action in contributing to the metabolic dysfunction. In general adrenal surgery in cases of aldosterone-producing adenoma will correct the metabolic abnormalities, but it is less sure if treatment with spironolactone in cases of idiopathic hyperplasia will correct impaired glucose tolerance.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12642008     DOI: 10.1007/s11906-003-0065-2

Source DB:  PubMed          Journal:  Curr Hypertens Rep        ISSN: 1522-6417            Impact factor:   5.369


  28 in total

Review 1.  CLINICAL CHARACTERISTICS OF PRIMARY ALDOSTERONISM FROM AN ANALYSIS OF 145 CASES.

Authors:  J W CONN; R F KNOPF; R M NESBIT
Journal:  Am J Surg       Date:  1964-01       Impact factor: 2.565

2.  Serum leptin levels in patients with primary hyperaldosteronism before and after treatment: relationships to insulin sensitivity.

Authors:  M Haluzík; G Sindelka; J Widimský; M Prázný; T Zelinka; J Skrha
Journal:  J Hum Hypertens       Date:  2002-01       Impact factor: 3.012

3.  Can primary hyperaldosteronism be considered as a specific form of diabetes mellitus?

Authors:  J Widimský; B Strauch; G Sindelka; J Skrha
Journal:  Physiol Res       Date:  2001       Impact factor: 1.881

4.  Inhibition by aldosterone of insulin receptor mRNA levels and insulin binding in U-937 human promonocytic cells.

Authors:  J Campión; B Maestro; F Mata; N Dávila; M C Carranza; C Calle
Journal:  J Steroid Biochem Mol Biol       Date:  1999 Sep-Oct       Impact factor: 4.292

5.  [A case of nephrotic syndrome with diabetes mellitus and primary aldosteronism].

Authors:  H Mani; K Takeda; M Kiyama; S Morimoto; T Nakata; S Sasaki; M Nakagawa
Journal:  Nihon Jinzo Gakkai Shi       Date:  1999-06

6.  Aldosterone impairs insulin responsiveness in U-937 human promonocytic cells via the downregulation of its own receptor.

Authors:  J Campión; B Maestro; S Molero; N Dávila; M C Carranza; C Calle
Journal:  Cell Biochem Funct       Date:  2002-09       Impact factor: 3.685

7.  [Decreased insulin receptor number and affinity in subcutaneous adipose tissue in a patient with primary hyperaldosteronism].

Authors:  M C Carranza; A Torres; C Calle
Journal:  Rev Clin Esp       Date:  1991-05       Impact factor: 1.556

8.  Inhibition of lipopolysaccharide-induced monocyte interleukin-1 receptor antagonist synthesis by cortisol: involvement of the mineralocorticoid receptor.

Authors:  J Sauer; M Castren; U Hopfner; F Holsboer; G K Stalla; E Arzt
Journal:  J Clin Endocrinol Metab       Date:  1996-01       Impact factor: 5.958

9.  In vivo tissue specific modulation of rat insulin receptor gene expression in an experimental model of mineralocorticoid excess.

Authors:  J Campión; V Lahera; V Cachofeiro; B Maestro; N Dávila; M C Carranza; C Calle
Journal:  Mol Cell Biochem       Date:  1998-08       Impact factor: 3.396

10.  Increased insulin sensitivity in patients with aldosterone producing adenoma.

Authors:  M Ishimori; N Takeda; S Okumura; T Murai; H Inouye; K Yasuda
Journal:  Clin Endocrinol (Oxf)       Date:  1994-10       Impact factor: 3.478

View more
  13 in total

Review 1.  The role of aldosterone in cardiovascular disease in people with diabetes and hypertension: an update.

Authors:  Guido Lastra-Gonzalez; Camila Manrique-Acevedo; James R Sowers
Journal:  Curr Diab Rep       Date:  2008-06       Impact factor: 4.810

2.  Aldosterone, Renin, and Diabetes Mellitus in African Americans: The Jackson Heart Study.

Authors:  Joshua J Joseph; Justin B Echouffo-Tcheugui; Rita R Kalyani; Hsin-Chieh Yeh; Alain G Bertoni; Valery S Effoe; Ramon Casanova; Mario Sims; Adolfo Correa; Wen-Chih Wu; Gary S Wand; Sherita H Golden
Journal:  J Clin Endocrinol Metab       Date:  2016-02-23       Impact factor: 5.958

3.  The Association of ARMC5 with the Renin-Angiotensin-Aldosterone System, Blood Pressure, and Glycemia in African Americans.

Authors:  Joshua J Joseph; Xiaofei Zhou; Mihail Zilbermint; Constantine A Stratakis; Fabio R Faucz; Maya B Lodish; Annabel Berthon; James G Wilson; Willa A Hsueh; Sherita H Golden; Shili Lin
Journal:  J Clin Endocrinol Metab       Date:  2020-08-01       Impact factor: 5.958

4.  Potassium and risk of Type 2 diabetes.

Authors:  Ranee Chatterjee; Hsin-Chieh Yeh; David Edelman; Frederick Brancati
Journal:  Expert Rev Endocrinol Metab       Date:  2011-09

Review 5.  The metabolic syndrome in primary aldosteronism.

Authors:  Francesco Fallo; Giovanni Federspil; Franco Veglio; Paolo Mulatero
Journal:  Curr Diab Rep       Date:  2008-02       Impact factor: 4.810

6.  Non-Alcoholic Fatty Liver Disease and Hypokalemia in Primary Aldosteronism Among Chinese Population.

Authors:  Yi Chen; Xueyang Chen; Qiang Chen; Chaohui Yu
Journal:  Front Endocrinol (Lausanne)       Date:  2021-04-22       Impact factor: 5.555

7.  Visceral adipose tissue: emerging role of gluco- and mineralocorticoid hormones in the setting of cardiometabolic alterations.

Authors:  Marco Boscaro; Gilberta Giacchetti; Vanessa Ronconi
Journal:  Ann N Y Acad Sci       Date:  2012-07-17       Impact factor: 5.691

8.  Association of visceral adiposity and clinical outcome among patients with aldosterone producing adenoma.

Authors:  Leay Kiaw Er; Meng-Chun Lin; Yao-Chou Tsai; Jong-Kai Hsiao; Chung-Yi Yang; Chin-Chen Chang; Kang-Yung Peng; Jeff S Chueh; Vin-Cent Wu
Journal:  BMJ Open Diabetes Res Care       Date:  2020-07

9.  The Association of Life's Simple 7 with Aldosterone among African Americans in the Jackson Heart Study.

Authors:  Veena Kesireddy; Yubo Tan; David Kline; Guy Brock; James B Odei; Bjorn Kluwe; Valery S Effoe; Justin B Echouffo Tcheugui; Rita R Kalyani; Mario Sims; Herman A Taylor; Morgana Mongraw-Chaffin; Ehimare Akhabue; Joshua J Joseph
Journal:  Nutrients       Date:  2019-04-26       Impact factor: 5.717

Review 10.  The metabolic syndrome in primary aldosteronism.

Authors:  Francesco Fallo; Giovanni Federspil; Franco Veglio; Paolo Mulatero
Journal:  Curr Hypertens Rep       Date:  2007-04       Impact factor: 4.592

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.